TELEFLEX INC (TFX) Stock Price & Overview
NYSE:TFX • US8793691069
The current stock price of TFX is 111.88 USD. Today TFX is down by -1.26%. In the past month the price increased by 7.01%. In the past year, price decreased by -18.98%.
TFX Key Statistics
- Market Cap
- 4.945B
- P/E
- 9.14
- Fwd P/E
- 9.77
- EPS (TTM)
- 12.24
- Dividend Yield
- 1.16%
TFX Stock Performance
TFX Stock Chart
TFX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to TFX. When comparing the yearly performance of all stocks, TFX is a bad performer in the overall market: 79.51% of all stocks are doing better.
TFX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to TFX. Both the profitability and the financial health of TFX get a neutral evaluation. Nothing too spectacular is happening here.
TFX Earnings
On February 26, 2026 TFX reported an EPS of 1.93 and a revenue of 568.98M. The company missed EPS expectations (-48.83% surprise) and missed revenue expectations (-38.72% surprise).
TFX Forecast & Estimates
18 analysts have analysed TFX and the average price target is 137.93 USD. This implies a price increase of 23.28% is expected in the next year compared to the current price of 111.88.
For the next year, analysts expect an EPS growth of -6.4% and a revenue growth -12.37% for TFX
TFX Groups
Sector & Classification
TFX Financial Highlights
Over the last trailing twelve months TFX reported a non-GAAP Earnings per Share(EPS) of 12.24. The EPS decreased by -12.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.04% | ||
| ROE | -28.98% | ||
| Debt/Equity | 0.81 |
TFX Ownership
TFX Latest News, Press Relases and Analysis
TFX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.42 | 190.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.58 | 174.071B | ||
| SYK | STRYKER CORP | 23.92 | 139.513B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.5 | 105.876B | ||
| IDXX | IDEXX LABORATORIES INC | 40.39 | 48.442B | ||
| BDX | BECTON DICKINSON AND CO | 12.03 | 47.586B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 47.376B | ||
| RMD | RESMED INC | 20.46 | 36.838B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.34 | 33.849B | ||
| DXCM | DEXCOM INC | 26.57 | 26.209B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.9 | 18.413B | ||
| HOLX | HOLOGIC INC | 15.39 | 16.908B | ||
| PODD | INSULET CORP | 36.44 | 16.686B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TFX
Company Profile
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Company Info
TELEFLEX INC
550 E Swedesford Rd, Suite 400
Wayne PENNSYLVANIA 19087 US
CEO: Liam J. Kelly
Employees: 14100
Phone: 16102256800
TELEFLEX INC / TFX FAQ
What does TELEFLEX INC do?
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
What is the current price of TFX stock?
The current stock price of TFX is 111.88 USD. The price decreased by -1.26% in the last trading session.
Does TFX stock pay dividends?
TELEFLEX INC (TFX) has a dividend yield of 1.16%. The yearly dividend amount is currently 1.33.
What is the ChartMill technical and fundamental rating of TFX stock?
TFX has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for TFX stock?
18 analysts have analysed TFX and the average price target is 137.93 USD. This implies a price increase of 23.28% is expected in the next year compared to the current price of 111.88.
What is the expected growth for TFX stock?
The Revenue of TELEFLEX INC (TFX) is expected to decline by -12.37% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for TELEFLEX INC?
TELEFLEX INC (TFX) has a market capitalization of 4.95B USD. This makes TFX a Mid Cap stock.